Bleeding Disorder Testing Global Market Report 2025
상품코드:1825635
리서치사:The Business Research Company
발행일:On Demand Report
페이지 정보:영문 250 Pages
라이선스 & 가격 (부가세 별도)
ㅁ Add-on 가능: 고객의 요청에 따라 일정한 범위 내에서 Customization이 가능합니다. 자세한 사항은 문의해 주시기 바랍니다.
ㅁ 보고서에 따라 최신 정보로 업데이트하여 보내드립니다. 배송기일은 문의해 주시기 바랍니다.
한글목차
출혈 장애 검사 시장 규모는 향후 수년간 강력한 성장이 예상됩니다. 2029년 연평균 성장률(CAGR)은 7.8%를 나타낼 것으로 예측되고 218억 7,000만 달러로 성장할 전망입니다. 예측 기간 동안의 성장은 혈우병 유병률 증가, 출혈 장애 증상에 대한 인식 제고, 진단 연구 투자 확대, 전 세계 의료비 지출 증가, 희귀 출혈 장애 유병률 증가 등에 기인할 수 있습니다. 예측 기간의 주요 동향으로는 기술적 발전, 인공지능 통합, 맞춤형 의약품, 원격 의료 서비스, 가정용 검사 키트 등이 포함됩니다.
향후 5년간 7.8% 성장 전망은 이전 예측 대비 0.2% 소폭 하향 조정된 수치입니다. 이 같은 하향 조정은 주로 미국과 타국 간 관세 영향 때문입니다. 관세 인상으로 스위스 및 프랑스산 응고 분석기 및 요인 결핍 검사 키트의 공급원 비용이 상승하여 미국 혈액학 분야에 부담이 될 전망이며, 이로 인해 진단 지연이 악화되고 응고 검사실 운영 비용이 증가할 것입니다. 상호 보복 관세와 무역 긴장 및 제한 강화로 인한 전 세계 경제 및 무역에 대한 부정적 영향으로 그 효과는 더욱 광범위하게 나타날 것입니다.
임상 시험 건수 증가가 향후 몇 년간 출혈 장애 시험 시장 성장을 촉진할 것으로 예상됩니다. 새로운 의료 치료법, 요법, 의약품 또는 기술의 안전성과 효과를 인간을 대상으로 평가하는 연구인 임상 시험이 증가 추세에 있습니다. 이러한 증가는 의학 연구의 발전, 의료 혁신에 대한 투자 증가, 새로운 치료법 및 요법에 대한 수요 증가에 의해 촉진되고 있습니다. 이러한 시험에서 출혈 장애 검사는 출혈 장애에 대한 새로운 의약품 및 치료법의 효능과 안전성을 평가하고, 응고 이상을 관리하거나 교정하는 능력을 평가하며, 최적의 투여량과 효과를 보장하기 위해 환자 반응을 모니터링하는 데 매우 중요합니다. 예를 들어 미국의 임상시험 등록기관인 ClinicalTrials.gov에 따르면 2023년 말까지 약 477,228건의 임상시험이 등록되어 2022년 437,507건에서 증가하고 있습니다. 따라서 임상시험 건수의 증가는 출혈 장애 시험 시장의 확장을 촉진하고 있습니다.
목차
제1장 주요 요약
제2장 시장 특징
제3장 시장 동향과 전략
제4장 시장 : 금리, 인플레이션, 지정학, 무역전쟁과 관세, 그리고 코로나 및 회복이 시장에 미치는 영향을 포함한 거시경제 시나리오
제5장 세계의 성장 분석과 전략 분석 프레임워크
세계의 출혈 장애 검사 : PESTEL 분석(정치, 사회, 기술, 환경, 법적 요인, 촉진요인과 억제요인)
최종 이용 산업의 분석
세계의 출혈 장애 검사 시장 : 성장률 분석
세계의 출혈 장애 검사 시장 실적 : 규모와 성장(2019-2024년)
세계의 출혈 장애 검사 시장 예측 : 규모와 성장(2024-2029년, 2034년)
세계의 출혈 장애 검사 : 총 잠재시장 규모(TAM)
제6장 시장 세분화
세계의 출혈 장애 검사 시장 : 제품 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
시약 및 소모품
기기
세계의 출혈 장애 검사 시장 : 적응증별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
혈우병 A
혈우병 B
폰 빌레브란트병
특발성 혈소판 감소성 자반증
기타 적응증
세계의 출혈 장애 검사 시장 : 치료 유형별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
요인 대체 치료
약물 치료
세계의 출혈 장애 검사 시장 : 최종 사용자별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
병원 및 진료소
진단센터
기타 최종 사용자
세계의 출혈 장애 검사 시장, 시약 및 소모품 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
응고 시약
혈장 및 혈액 채취용 소모품
지혈 시약
요인 결핍 검사 키트
활성화 부분 트롬보플라스틴 시간(APTT) 시약
세계의 출혈 장애 검사 시장, 기기 유형별 세분화 : 분석과 예측(2019-2024년, 2024-2029년, 2034년)
응고 분석 기기
혈소판 기능 분석 기기
지혈 검사 기기
현장 검사 기기
자동 혈액 검사 시스템
제7장 지역별 및 국가별 분석
세계의 출혈 장애 검사 시장 : 지역별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
세계의 출혈 장애 검사 시장 : 국가별, 분석과 예측(2019-2024년, 2024-2029년, 2034년)
제8장 아시아태평양 시장
제9장 중국 시장
제10장 인도 시장
제11장 일본 시장
제12장 호주 시장
제13장 인도네시아 시장
제14장 한국 시장
제15장 서유럽 시장
제16장 영국 시장
제17장 독일 시장
제18장 프랑스 시장
제19장 이탈리아 시장
제20장 스페인 시장
제21장 동유럽 시장
제22장 러시아 시장
제23장 북미 시장
제24장 미국 시장
제25장 캐나다 시장
제26장 남미 시장
제27장 브라질 시장
제28장 중동 시장
제29장 아프리카 시장
제30장 경쟁 구도와 기업 프로파일
출혈 장애 검사 시장 : 경쟁 구도
출혈 장애 검사 시장 : 기업 프로파일
Pfizer Inc. : 개요, 제품 및 서비스, 전략 및 재무 분석
F. Hoffmann-La Roche Ltd. : 개요, 제품 및 서비스, 전략 및 재무 분석
Bayer AG : 개요, 제품 및 서비스, 전략 및 재무 분석
Takeda Pharmaceutical Company Limited : 개요, 제품 및 서비스, 전략 및 재무 분석
Novo Nordisk A/S : 개요, 제품 및 서비스, 전략 및 재무 분석
제31장 기타 주요 기업 및 혁신 기업
Siemens Healthcare GmbH
Baxter International Inc.
CSL Limited
Octapharma AG
HORIBA Ltd.
Haemonetics Corporation
Diagnostica Stago SAS
Sekisui Diagnostics LLC
Helena Laboratories Corporation
LFB Group
Sysmex Inostics GmbH
Medexus Pharmaceuticals Inc.
Precision Biologics Inc.
Corgenix Inc.
Diapharma Group Inc.
제32장 세계 시장 경쟁 벤치마킹과 대시보드
제33장 주요 인수합병(M&A)
제34장 최근 시장 동향
제35장 시장의 잠재력이 높은 국가, 부문, 전략
출혈 장애 검사 시장(2029년) : 새로운 기회를 제공하는 국가
출혈 장애 검사 시장(2029년) : 새로운 기회를 제공하는 부문
출혈 장애 검사 시장(2029년) : 성장 전략
시장 동향에 기초한 전략
경쟁 전략
제36장 부록
HBR
영문 목차
영문목차
Bleeding disorder testing encompasses a variety of diagnostic methods aimed at assessing the function and composition of blood to detect abnormalities associated with bleeding disorders. These tests evaluate clotting ability, platelet function, and specific deficiencies or dysfunctions of clotting factors.
The primary product categories for bleeding disorder testing are reagents and consumables, as well as instruments. The reagents and consumables segment includes the chemical substances, materials, and disposable items utilized in the diagnosis and analysis of bleeding disorders. This category features test kits, reagents, and other necessary supplies for performing these tests. Common indications for these tests include hemophilia A, hemophilia B, von Willebrand disease, idiopathic thrombocytopenic purpura, among others. Treatments generally involve factor replacement therapy and drug therapy, and the tests are used by various end-users, such as hospitals, clinics, and diagnostic centers.
Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.
The sharp rise in U.S. tariffs and the resulting trade tensions in spring 2025 are having a significant impact on the healthcare sector, especially in the supply of essential medical devices, diagnostic equipment, and pharmaceuticals. Hospitals and healthcare providers are grappling with higher costs for imported surgical tools, imaging systems, and consumables like syringes and catheters, many of which have limited domestic substitutes. These escalating expenses are putting pressure on healthcare budgets, prompting some providers to delay equipment upgrades or pass increased costs on to patients. Furthermore, tariffs on raw materials and components are disrupting the manufacturing of vital drugs and devices, leading to supply chain delays. In response, the industry is adopting diversified sourcing strategies, expanding local production where feasible, and pushing for tariff exemptions on critical medical products.
The bleeding disorder testing market research report is one of a series of new reports from The Business Research Company that provides bleeding disorder testing market statistics, including bleeding disorder testing industry global market size, regional shares, competitors with a bleeding disorder testing market share, detailed bleeding disorder testing market segments, market trends, and opportunities, and any further data you may need to thrive in the bleeding disorder testing industry. This bleeding disorder testing research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.
The bleeding disorder testing market size has grown strongly in recent years. It will grow from $14.99 billion in 2024 to $16.18 billion in 2025 at a compound annual growth rate (CAGR) of 8.0%. The growth in the historic period can be attributed to the increasing prevalence of bleeding disorders, increasing investment in research and development, a growing number of specialized clinics, increasing demand for early diagnosis, and a rising number of clinical trials.
The bleeding disorder testing market size is expected to see strong growth in the next few years. It will grow to $21.87 billion in 2029 at a compound annual growth rate (CAGR) of 7.8%. The growth in the forecast period can be attributed to the increasing prevalence of hemophilia rising awareness of bleeding disorder symptoms, increasing investment in diagnostic research, rising healthcare spending globally, and rising prevalence of rare bleeding disorders. Major trends in the forecast period include technological advancements, integration of artificial intelligence, personalized medicine, telemedicine services, and home-based testing kits.
The forecast of 7.8% growth over the next five years reflects a slight reduction of 0.2% from the previous projection. This reduction is primarily due to the impact of tariffs between the US and other countries. Tariff escalations are likely to burden U.S. hematology by driving up the cost of coagulation analyzers and factor deficiency test kits sourced from Switzerland and France, exacerbating diagnostic delays and increasing coagulation lab operational costs. The effect will also be felt more widely due to reciprocal tariffs and the negative effect on the global economy and trade due to increased trade tensions and restrictions.
The increasing number of clinical trials is anticipated to boost the growth of the bleeding disorder testing market in the coming years. Clinical trials, which are research studies that evaluate the safety and effectiveness of new medical treatments, therapies, medicines, or technologies in humans, are on the rise. This increase is driven by advancements in medical research, growing investment in healthcare innovation, and the rising demand for new treatments and therapies. In these trials, bleeding disorder testing is crucial for assessing the efficacy and safety of new medicines and therapies for bleeding disorders, evaluating their ability to manage or correct clotting abnormalities, and monitoring patient responses to ensure optimal dosing and effectiveness. For example, according to ClinicalTrials.gov, a US-based clinical trial registry, approximately 477,228 clinical trials were registered by the end of 2023, up from 437,507 in 2022. Thus, the growing number of clinical trials is propelling the bleeding disorder testing market's expansion.
Leading companies in the bleeding disorder testing market are focusing on developing innovative products, such as gene therapy for Hemophilia B, to provide long-term solutions, cure genetic bleeding disorders, improve treatment outcomes, and broaden their market presence. Hemophilia B, characterized by a deficiency of clotting factor IX necessary for proper blood coagulation, is a specific type of bleeding disorder. Gene therapy for Hemophilia B is an emerging treatment that aims to offer a long-term solution by addressing the underlying genetic defect causing the condition. For instance, in February 2023, CSL Limited, an Australia-based biotechnology company, received conditional marketing authorization (CMA) from the European Commission for HEMGENIX, the first and only one-time gene therapy for treating severe and moderately severe Hemophilia B. This innovative treatment aims to provide long-lasting efficacy, potentially reducing or eliminating the need for regular factor replacement therapy and significantly altering the standard of care for Hemophilia B patients.
In May 2022, Sema4, a US-based company specializing in genetic testing and data-driven patient insights, acquired GeneDx, LLC for $150 million. This acquisition aims to enhance Sema4's genetic testing capabilities by integrating GeneDx's expertise in genetic diagnostics for rare and inherited disorders, including bleeding disorders. GeneDx LLC, also based in the US, offers testing related to bleeding disorders as part of its comprehensive genetic diagnostic services.
Major companies operating in the bleeding disorder testing market are Pfizer Inc., F. Hoffmann-La Roche Ltd., Bayer AG, Takeda Pharmaceutical Company Limited, Novo Nordisk A/S, Siemens Healthcare GmbH, Baxter International Inc., CSL Limited, Octapharma AG, HORIBA Ltd., Haemonetics Corporation, Diagnostica Stago S.A.S., Sekisui Diagnostics LLC, Helena Laboratories Corporation, LFB Group, Sysmex Inostics GmbH, Medexus Pharmaceuticals Inc., Precision Biologics Inc., Corgenix Inc., Diapharma Group Inc., Hyphen BioMed, Hema Biologics LLC
North America was the largest region in the bleeding disorder testing market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the bleeding disorder testing market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the bleeding disorder testing market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.
The bleeding disorder testing market consists of revenues earned by entities by providing services such as complete blood count (CBC), prothrombin time (PT), activated partial thromboplastin time (aPTT), and genetic testing. The market value includes the value of related goods sold by the service provider or included within the service offering. The bleeding disorder testing market also includes sales of coagulation analyzers, platelet aggregation analyzers, blood collection devices, genetic testing kits, and bleeding time test kits. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Bleeding Disorder Testing Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses on bleeding disorder testing market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Reasons to Purchase
Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
Create regional and country strategies on the basis of local data and analysis.
Identify growth segments for investment.
Outperform competitors using forecast data and the drivers and trends shaping the market.
Understand customers based on the latest market shares.
Benchmark performance against key competitors.
Suitable for supporting your internal and external presentations with reliable high quality data and analysis
Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
All data from the report will also be delivered in an excel dashboard format.
Where is the largest and fastest growing market for bleeding disorder testing ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The bleeding disorder testing market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
The market characteristics section of the report defines and explains the market.
The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
The forecasts are made after considering the major factors currently impacting the market. These include:
The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
Market segmentations break down the market into sub markets.
The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope
Markets Covered:1) By Product Type: Reagents And Consumables; Instruments
2) By Indication: Hemophilia A; Hemophilia B; Von Willebrand Disease; Idiopathic Thrombocytopenic Purpura; Other Indications
3) By Treatment Type: Factor Replacement Therapy; Drug Therapy
4) By End User: Hospitals And Clinics; Diagnostic Centers; Other End Users
Subsegments:
1) By Reagents And Consumables: Coagulation Reagents; Plasma And Blood Collection Consumables; Hemostasis Reagents; Factor Deficiency Assay Kits; Activated Partial Thromboplastin Time (APTT) Reagents
2) By Instruments: Coagulation Analyzers; Platelet Function Analyzers; Hemostasis Testing Instruments; Point-Of-Care Testing Devices; Automated Blood Testing Systems
Companies Mentioned: Pfizer Inc.; F. Hoffmann-La Roche Ltd.; Bayer AG; Takeda Pharmaceutical Company Limited; Novo Nordisk A/S; Siemens Healthcare GmbH; Baxter International Inc.; CSL Limited; Octapharma AG; HORIBA Ltd.; Haemonetics Corporation; Diagnostica Stago S.A.S.; Sekisui Diagnostics LLC; Helena Laboratories Corporation; LFB Group; Sysmex Inostics GmbH; Medexus Pharmaceuticals Inc.; Precision Biologics Inc.; Corgenix Inc.; Diapharma Group Inc.; Hyphen BioMed; Hema Biologics LLC
3. Bleeding Disorder Testing Market Trends And Strategies
4. Bleeding Disorder Testing Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
4.1. Supply Chain Impact from Tariff War & Trade Protectionism
5. Global Bleeding Disorder Testing Growth Analysis And Strategic Analysis Framework
5.1. Global Bleeding Disorder Testing PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Bleeding Disorder Testing Market Growth Rate Analysis
5.4. Global Bleeding Disorder Testing Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Bleeding Disorder Testing Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Bleeding Disorder Testing Total Addressable Market (TAM)
6. Bleeding Disorder Testing Market Segmentation
6.1. Global Bleeding Disorder Testing Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Reagents And Consumables
Instruments
6.2. Global Bleeding Disorder Testing Market, Segmentation By Indication, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hemophilia A
Hemophilia B
Von Willebrand Disease
Idiopathic Thrombocytopenic Purpura
Other Indications
6.3. Global Bleeding Disorder Testing Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Factor Replacement Therapy
Drug Therapy
6.4. Global Bleeding Disorder Testing Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Hospitals And Clinics
Diagnostic Centers
Other End Users
6.5. Global Bleeding Disorder Testing Market, Sub-Segmentation Of Reagents And Consumables, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Coagulation Reagents
Plasma And Blood Collection Consumables
Hemostasis Reagents
Factor Deficiency Assay Kits
Activated Partial Thromboplastin Time (APTT) Reagents
6.6. Global Bleeding Disorder Testing Market, Sub-Segmentation Of Instruments, By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Coagulation Analyzers
Platelet Function Analyzers
Hemostasis Testing Instruments
Point-Of-Care Testing Devices
Automated Blood Testing Systems
7. Bleeding Disorder Testing Market Regional And Country Analysis
7.1. Global Bleeding Disorder Testing Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Bleeding Disorder Testing Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
